Nasdaq
BCAB
BioAtla, Inc.
- Health Care
- Listed 2020
- 1 day
- +0.1%
- 1 month
- −18.4%
- 1 year
- −82.2%
$3.33 · Mkt cap $5.53M
At the 6 Aug 2026 close
Nasdaq
BioAtla, Inc.
$3.33 · Mkt cap $5.53M
At the 6 Aug 2026 close
BioAtla, Inc. trades under the ticker BCAB on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2020. Its market capitalisation is $5.53M. The last closing price was $3.33, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −82.2%, and −18.4% over the past month. Returns are price returns and exclude dividends.
This page exists because BCAB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.